---
figid: PMC9650835__12931_2022_2226_Fig6_HTML
pmcid: PMC9650835
image_filename: 12931_2022_2226_Fig6_HTML.jpg
figure_link: /pmc/articles/PMC9650835/figure/Fig6/
number: Fig. 6
figure_title: ''
caption: Gene Set Variation Analysis (GSVA) compares cellular, molecular, and immune
  characteristics of the four UrCCG subtypes based on KEGG, HALLMARK, or GO signatures.
  A–P Enrichment scores of the cell cycle (A), regulation of autophagy (B), mismatch
  repair (C), MTORC1 signaling (D), MYC-targets V2 (E), reactive oxygen species pathway
  (F), unfolded protein response (G), nucleotide expression repair (H), PI3K/AKT/mTOR
  (I), B cell receptor pathway (J), p53 pathway (K), EMT (L), alpha–beta T (αβT)-cell
  activation (M), natural killer cell differentiation (N), T helper 1 type immune
  response (O), and activation-induced cell death of T cells (P). *p < 0.05, **p < 0.01,
  and ***p < 0.001
article_title: Pan-cancer analysis of UBE2T with a focus on prognostic and immunological
  roles in lung adenocarcinoma.
citation: Kui Cao, et al. Respir Res. 2022;23:306.
year: '2022'

doi: 10.1186/s12931-022-02226-z
journal_title: Respiratory Research
journal_nlm_ta: Respir Res
publisher_name: BioMed Central

keywords:
- Pan-cancer
- UBE2T
- Risk signature
- Consensus clustering
- Tumor immune infiltration
- LUAD

---
